Churchill Capital Corp XI (CCXI)vsChurchill Capital Corp VII Class A Common Stock (CVII)
CCXI
Churchill Capital Corp XI
$10.22
-0.10%
FINANCIAL SERVICES · Cap: $573.15M
CVII
Churchill Capital Corp VII Class A Common Stock
$9.99
0.00%
FINANCIAL SERVICES · Cap: $914.73M
Smart Verdict
WallStSmart Research — data-driven comparison
CVII leads profitability with a 0.0% profit margin vs 0.0%. CVII earns a higher WallStSmart Score of 40/100 (F).
CCXI
Avoid24
out of 100
Grade: F
CVII
Hold40
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
Earnings expanding 113.7% YoY
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Areas to Watch
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
ROE of 4.7% — below average capital efficiency
0.0% revenue growth
Smaller company, higher risk/reward
ROE of 0.0% — below average capital efficiency
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : CCXI
CCXI has a balanced fundamental profile.
Bull Case : CVII
The strongest argument for CVII centers on EPS Growth, Debt/Equity, Altman Z-Score.
Bear Case : CCXI
The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.
Bear Case : CVII
The primary concerns for CVII are Revenue Growth, Market Cap, Return on Equity.
Key Dynamics to Monitor
CVII is growing revenue faster at 0.0% — sustainability is the question.
CCXI generates stronger free cash flow (-326,107), providing more financial flexibility.
Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
CVII scores higher overall (40/100 vs 24/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Churchill Capital Corp XI
FINANCIAL SERVICES · SHELL COMPANIES · USA
ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.
Churchill Capital Corp VII Class A Common Stock
FINANCIAL SERVICES · SHELL COMPANIES · USA
Churchill Capital Corp VII focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more companies. The company is headquartered in New York, New York.
Compare with Other SHELL COMPANIES Stocks
Want to dig deeper into these stocks?